Open AccessLevel of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria
Author(s) -
Akinyemi O. D. Ofakunrin,
Edache S. Okpe,
Tolulope Afolaranmi,
Rasaq Olaosebikan,
Patience U. Kanhu,
Kehinde Adekola,
Nantok Dami,
Atiene S. Sagay
Publication year - 2021
Publication title -
african health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 44
eISSN - 1729-0503
pISSN - 1680-6905
DOI - 10.4314/ahs.v21i2.36
Subject(s) - medicine , logistic regression , disease , cross sectional study , health care , family medicine , intensive care medicine , pediatrics , pathology , economics , economic growth
Hydroxyurea is underutilized by sickle cell health-care providers in Nigeria despite available evidence of its effectiveness in reducing the manifestations and complications of sickle cell disease (SCD).